Medicare Doughnut Hole

(redirected from Medicare Part D Coverage Gap)
Also found in: Wikipedia.
Formally known as the Medicare Part D Coverage Gap. The difference between the initial coverage limit and the catastrophic coverage threshold, as described in the Medicare Part D prescription drug program. After a Medicare beneficiary surpasses the prescription drug coverage limit, the Medicare beneficiary is financially responsible for the entire cost of prescription drugs until the expense reaches the catastrophic coverage threshold, fancifully likened to a doughnut which provides pleasure to the consumer until he hits the centre—no joy—then returns to the happy part
References in periodicals archive ?
Require pharmaceutical manufacturers to offer a 50 percent discount on brand-name prescriptions filled in the Medicare Part D coverage gap beginning in 2011, and begin phasing in federal subsidies for generic prescriptions filled in the Medicare Part D coverage gap.
Begin phasing in federal subsidies for brand-name prescriptions filled in the Medicare Part D coverage gap.
We examined the effect of the Medicare Part D coverage gap on drug costs and adherence among beneficiaries with diabetes in two large health systems offering MAPD plans.
Nearly two-thirds of enrollees don't fully understand the Medicare Part D Coverage Gap
Seniors Struggling with the Medicare Coverage Gap," nearly two-thirds of enrollees don't fully understand the Medicare Part D Coverage Gap -- the portion of Part D plans in which beneficiaries must cover the full cost of their prescriptions.
New functionality for pharmaceutical manufacturers to help manage the requirements of the Medicare Part D coverage gap program and minimize risk
During 2007, the Medicare Part D Coverage Gap took effect when beneficiaries' total drug costs reached $2,400.
Under health care reform, the Medicare Part D coverage gap will be phased out by 2020.
8 million people with Medicare have received discounts on brand-name drugs in the Medicare Part D coverage gap, also known as the "donut hole," between January and August of this year.
Seniors with sufficient prescription drug use to have reached the Medicare Part D coverage gap were the focus in this analysis of 114,766 patients, using time-trend analyses of dispensing data from three large pharmacy chains.
Verispan's de-identified patient data coupled with The Amundsen Group's expert analysis will provide the truest, most clear picture of how patients are faring with regard to the Medicare Part D coverage gap.
Full browser ?